Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials.

Source:http://linkedlifedata.com/resource/pubmed/id/15094759

Download in:

View as

General Info

PMID
15094759